Active substance
Results for the substance thyrotropin alfa
1 result
About this active substance
Thyrotropin alfa is a recombinant hormone used in the diagnosis and treatment of differentiated thyroid cancer. It stimulates the thyroid gland to produce thyroglobulin, an important marker for monitoring thyroid cancer patients after thyroidectomy.
The medication is administered via intramuscular injection, usually in two separate doses, as directed by a doctor. It is used in combination with radioactive iodine to detect metastases or residual thyroid tissue.
Patients should be monitored for potential side effects, such as nausea, headache, or injection site reactions. It is important for patients to inform their doctor of any unusual symptoms.
Common side effects include nausea, fatigue, dizziness, and pain at the injection site. In rare cases, severe allergic reactions may occur. Patients should be informed of these risks before administration.
The medication is administered via intramuscular injection, usually in two separate doses, as directed by a doctor. It is used in combination with radioactive iodine to detect metastases or residual thyroid tissue.
Patients should be monitored for potential side effects, such as nausea, headache, or injection site reactions. It is important for patients to inform their doctor of any unusual symptoms.
Common side effects include nausea, fatigue, dizziness, and pain at the injection site. In rare cases, severe allergic reactions may occur. Patients should be informed of these risks before administration.